Search for Clinical Trial Results

Sponsored By

Sex Cord-Gonadal Stromal Tumors - 12 Studies Found

Status Study
Active, not recruiting Study Name: Efficacy and Safety of Bevacizumab (Avastin®) Combined to Weekly Paclitaxel Followed by Bevacizumab (Avastin®) Alone in Patients With Relapsed Ovarian Sex-cord Stromal Tumours (ALIENOR)
Condition: Ovarian Sex-cord Stromal Tumor
Date: 2013-01-15
Interventions:
  • Drug: Paclitaxel
  • Drug: Bevacizumab
Enrolling by invitation Study Name: TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors
Condition:
  • Ovarian Sex Cord Stromal Tumor
  • Ovarian Neoplasms
  • Date: 2015-04-24
    Interventions:
    • Drug: Paclitaxel Patients rece
Active, not recruiting Study Name: Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary
Condition:
  • Malignant Ovarian Epithelial Tumor
  • Ovarian Granulosa Cell Tumor
  • Biological: Bevacizumab Given

Completed Study Name: Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors
Condition:
  • Childhood Germ Cell Tumor
  • Leydig Cell Tumor
  • Ovarian Cancer
    Date: 2012-04-05
    Interventions:
    • Genetic: RNA analysis
    • Genetic: gene expres
Recruiting Study Name: Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors
Condition:
  • Ovarian Granulosa Cell Tumor
  • Ovarian Gynandroblastoma
  • Ovar
    Date: 2010-01-01
    Interventions:
    • Biological: Bleomycin Sulfate

Completed Study Name: Paclitaxel in Treating Patients With Ovarian Stromal Cancer
Condition:
  • Adult Type Ovarian Granulosa Cell Tumor
  • Ovarian Gynandroblastoma
  • Acinar Cell Carcinoma
  • Adrenal Cortex Carcinoma
  • Adrenal Gla
    Date: 2016-07-13
    Interventions:
    • Procedure: Biospecimen Collection

Terminated Study Name: Ketoconazole as Inhibitor of the Enzyme CYP17 in Locally Advanced or Disseminated Granulosa Cell Tumour of Ovary
Condition: Granulosa Cell Tumour of the Ovary
Date: 2012-04-22
Interventions: Drug: Ketoconazole Patients will receive ketoconazole, 400 mg three times a day. Study treatment period
Completed Study Name: Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Condition:
  • Anxiety Disorder
  • Depression
  • Fatigue
  • Other: questionnaire administration

Completed Study Name: Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Condition:
  • Leydig Cell Tumor
  • Ovarian Sarcoma
  • Ovarian Stromal Cancer Date: 2012-07-26
    Interventions:
    • Radiation: stereotactic body radiation therapy

Next >>>